Xiaowen Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaowen Jiang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Huiyuan Gao
School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China
4 shared publications - Hongyuan Lu
Department of Clinical Pharmacology, China Medical University, Shenyang, PR China
2 shared publications - Qingchun Zhao
Shenyang Pharmaceutical University
2 shared publications Yue Jin
School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, PR China
2 shared publications- Chuanzhi Kang
State Key Laboratory for Quality Assurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China
1 shared publication Huilin Zhu
School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, PR China; Key Laboratory of Pharmacodynamic Substances Research & Translational Medicine of Immune Diseases of Shenyang, Shenyang Pharmaceutical University, Shenyang 110016, PR China; Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China
1 shared publication
Latest Publications
- Open Access
- 24 September 2026
- Published by Elsevier in Pharmacological Research
- Vol. 233, 108479
DHA in Alzheimer’s disease: The translational gap between mechanistic complexity and clinical inconsistency
- 24 September 2026
- Published by Elsevier in Pharmacological Research
- Vol. 233, 108479
Open AccessDHA in Alzheimer’s disease: The translational gap between mechanistic complexity and clinical inconsistency
- Open Access
- 30 March 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (6) , 3257-3291
Recent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies
- 30 March 2026
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 16 (6) , 3257-3291
Open AccessRecent advances in antiviral drugs for Chikungunya virus (CHIKV): Targets, mechanisms, and development strategies
- 31 October 2024
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 113, 108267
Identify the key genes and pathways of melatonin in age-dependent mice hippocampus regulation by transcriptome analysis
- 31 October 2024
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 113, 108267
Identify the key genes and pathways of melatonin in age-dependent mice hippocampus regulation by transcriptome analysis
- 17 September 2024
- Published by Elsevier in Phytomedicine
- Vol. 135, 156068
A combined treatment with Ursolic acid and Solasodine inhibits colorectal cancer progression through the AKT1/ERK1/2-GSK-3β-β-catenin axis
- 17 September 2024
- Published by Elsevier in Phytomedicine
- Vol. 135, 156068
A combined treatment with Ursolic acid and Solasodine inhibits colorectal cancer progression through the AKT1/ERK1/2-GSK-3β-β-catenin axis
- 30 July 2024
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 276, 116729
Discovery of a novel Xanthone derivative P24 for anti-AD via targeting sTGFBR3
- 30 July 2024
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 276, 116729
Discovery of a novel Xanthone derivative P24 for anti-AD via targeting sTGFBR3